Anxiety and depression are considered triggers for cardiovascular diseases (CVDs). About one-fourth of patients attribute their cardiac condition development and establishment to these factors (
1,
2).
Anxiety, as the most primitive and common reaction to a cardiac event, can lead to tachycardia, hypertension, and increased cardiac output, and it can adversely affect physical performance and quality of life among cardiac patients. A high anxiety level can increase sudden cardiac death up to three folds and can affect the adherence of patients in terms of participation in cardiac rehabilitation (CR) (
3). According to a study, an association exists between anxiety and incident cardiac disease with a 26% increase in risk, and anxiety is also specifically associated with cardiac mortality, with anxious persons having a 48% increased risk of cardiac death (
4).
Depression is highly prevalent in cardiac patients. About 31% - 45% of patients with coronary artery disease (CAD), including those with stable CAD, unstable angina, or myocardial infarction (MI), suffer from clinically significant depressive symptoms (
5). Patients with CVD, who are also depressed, have a worse outcome than those who are not depressed (
6). Depression is associated with cardiac stress reactions (
7,
8) and can adversely affect the compliance of patients who actually require CR. Depression can lead to slow activity beginning, poor social adaptability, lower chance of return to work, and lower level of quality of life after a cardiac event. This psychiatric disorder can lead to future cardiac conditions and considerable morbidity and mortality in patients with established coronary artery disease (
9).
According to the results of a study (
2), psychological factors such as anxiety and depression have an important role in the attitude of patients toward CVDs risk factors. These risk factors are categorized into five classes, namely, biological, environmental, physiological, behavioral, and psychological (
3). The attitude of patients with awareness of any of the mentioned risk may likely have an important role in their health behavior (
10). The study by Saeidi et al. (
3) showed that patients who attribute their condition to physiological or psychological factors experience more anxiety than those who attribute the disease to behavioral factors. Therefore, patients’ cognitions in all stages of disease experience, including symptom perception, looking for a factor to attribute the disease to that particular factor, and change in personal behaviors, may extremely affect the progression of the disease and its treatment (
11).
In recent years, the association between disease risk factors and causative beliefs about CVDs has been investigated in several studies (
12,
13). Patients with more false beliefs and misconceptions about disease risk factors have been determined to have poorer physical performance (
14) and to experience more anxiety and depression than other patients (
15).
Although these studies have investigated the relationship between myths and misconceptions about the causes of the disease with anxiety and depression, note that a wide range of patients do not have a clear view about the cause of their disease (
1,
16). Thus, as indicated in the abovementioned studies, the assessment of these patients and their mental state, especially anxiety and depression, has been neglected.
In a recent study that examined 901 cardiac patients, 10.5% of the patients, especially older patients, were unaware of the causes of their CVD (
17). Thus, previous studies neglected the evaluation of the mental state of a wide range of patients and considered only patients’ misconceptions with a perceived risk factor.